AG9801

A phase II study of irinotecan, leucovorin and 5- fluorouracil in advanced gastric cancer.

Share

Trial Status

Completed

Cancer Type

Stomach Cancer

Aim

This trial was designed to assess the efficacy and toxicity of irinotecan, leucovorin, and 5-flourouracil for patients with advanced gastric cancer.

Trial Status

Completed

Cancer Type

Stomach Cancer

Aim

This trial was designed to assess the efficacy and toxicity of irinotecan, leucovorin, and 5-flourouracil for patients with advanced gastric cancer.

Principal Investigator

Professor Stephen Ackland, Medical Oncologist, Newcastle Calvary Mater Hospital, NSW
Dr David Storey, Upper GI Surgeon, Royal Prince Alfred Hospital, NSW